Who Paid My Doc
Lipiodol
Drug HCC Contrast Agent
NDC 67684-1901-1
General payments
$406,870
Research payments
$1,561,408
Through program year 2025, $406,870 in general payments and $1,561,408 in research payments were reported against Lipiodol (HCC Contrast Agent).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $228,288 | 179 |
| 2025 | Research | $444,254 | 12 |
| 2024 | General | $129,406 | 111 |
| 2024 | Research | $574,235 | 10 |
| 2023 | General | $49,176 | 42 |
| 2023 | Research | $542,919 | 7 |
Breakdown
The top 5 of 61 recipients; each share is of general payments naming this product in 2025.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
332 general · 29 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.